FEXINIDAZOLE, 600mg, wallet of 24 tabs., >35 kg

STD DORAFEXI6T1A

Valid Article

6.5.5.1 - African trypanosomiasis
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01CA03
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

FEXINIDAZOLE

Therapeutic Action

Antiparasitic, 5-nitroimidazole

Indications

Stage-1 and stage-2 gambiense sleeping sickness (human African trypanosomiasis-HAT)

Some restricted information has been hidden. Sign in to see this information

Instructions for use

  • Wallet of 14 tablets for children between 20 and 35 kg:
    • 1200 mg/d (2 tabs.): D1 to D4
    • 600 mg/d (1 tab.): D5 to D10
  • Wallet of 24 tablets for adults ≥ 35 kg:
    • 1800 mg/d (3 tabs.): D1 to D4
    • 1200 mg/d (2 tabs.): D5 to D10

Storage

Below 25°C - Protect from sunlight - Protect from humidity